← Leaderboards
Derrick Fouts
J. Craig Venter Institute, Inc.
$1,942,527
Attributed
$1,942,527
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2017–18$2M$1.5M$1M$500K$0
'17
'18
Funding mix
By agency
NIH$1,942,527 · 1
By mechanism
U19$1,942,527 · 1
Top collaborators
No co-investigators on record.
Most similar at J. Craig Venter Institute, Inc.
Same institution · by research overlap
- Mark D Adams$14,217,980
- Daniel H. Haft$1,582,365
- Jacques Ravel$2,385,623
- Suman Ranjan Das$13,719,966
- Eric W Schmidt$1,950,873
Others in their field
Other Emerging Leaders on “Antibiotic Resistance”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$25,064,821
- Bruce Blough · Research Triangle Institute$19,880,022
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Terry Roemer · Prokaryotics, Inc.$13,917,276
Research focus
Antibiotic ResistanceAntibioticsAntibiotic TherapyAreaAutomobile DrivingBacteriaBacterial GenesBacterial ResistanceBaseBiological ProcessCharacteristicsCollectionCommensal MicrobesCommunicable DiseasesDesignDiagnosisDna AnalysisDna MethylationDna Modification MethylasesDna Modification ProcessDrug ResistanceElementsEnterobacteriaceaeAcinetobacter Baumannii